DK1109937T3 - Fremgangsmåde til diagnosticering , monitorering, stadiebestemmelse og billeddiagnostisk undersögelse for forskellige cancere - Google Patents

Fremgangsmåde til diagnosticering , monitorering, stadiebestemmelse og billeddiagnostisk undersögelse for forskellige cancere

Info

Publication number
DK1109937T3
DK1109937T3 DK99946662T DK99946662T DK1109937T3 DK 1109937 T3 DK1109937 T3 DK 1109937T3 DK 99946662 T DK99946662 T DK 99946662T DK 99946662 T DK99946662 T DK 99946662T DK 1109937 T3 DK1109937 T3 DK 1109937T3
Authority
DK
Denmark
Prior art keywords
staging
imaging
monitoring
diagnosis
procedures
Prior art date
Application number
DK99946662T
Other languages
English (en)
Inventor
Susana Salceda
Yongming Sun
Herve Recipon
Robert Cafferkey
Original Assignee
Diadexus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37848825&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1109937(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Diadexus Inc filed Critical Diadexus Inc
Application granted granted Critical
Publication of DK1109937T3 publication Critical patent/DK1109937T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T29/00—Metal working
    • Y10T29/49—Method of mechanical manufacture
    • Y10T29/49002—Electrical device making
    • Y10T29/49108—Electric battery cell making

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK99946662T 1998-09-02 1999-09-01 Fremgangsmåde til diagnosticering , monitorering, stadiebestemmelse og billeddiagnostisk undersögelse for forskellige cancere DK1109937T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9888098P 1998-09-02 1998-09-02
PCT/US1999/019655 WO2000012758A1 (en) 1998-09-02 1999-09-01 A novel method of diagnosing, monitoring, staging, imaging and treating various cancers
US76397801A 2001-04-25 2001-04-25

Publications (1)

Publication Number Publication Date
DK1109937T3 true DK1109937T3 (da) 2009-03-09

Family

ID=37848825

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99946662T DK1109937T3 (da) 1998-09-02 1999-09-01 Fremgangsmåde til diagnosticering , monitorering, stadiebestemmelse og billeddiagnostisk undersögelse for forskellige cancere

Country Status (10)

Country Link
US (6) US7737255B1 (da)
EP (2) EP1109937B1 (da)
JP (4) JP2002523760A (da)
AT (1) ATE413466T1 (da)
CA (1) CA2341142A1 (da)
DE (1) DE69939874D1 (da)
DK (1) DK1109937T3 (da)
ES (1) ES2317704T3 (da)
PT (1) PT1109937E (da)
WO (1) WO2000012758A1 (da)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7037667B1 (en) 1998-06-01 2006-05-02 Agensys, Inc. Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
ATE413466T1 (de) 1998-09-02 2008-11-15 Diadexus Inc Verfahren zur diagnose, bewertung sowie bilddarstellung verschiedener krebserkrankungen
EP1728518A1 (en) * 1998-09-23 2006-12-06 Diadexus, Inc. Method of diagnosing monitoring, staging, imaging and treating gynecologic cancers and testicular cancer
JP2002526055A (ja) * 1998-09-23 2002-08-20 ダイアデクスアス・インコーポレーテッド 婦人科癌及び精巣癌を診断、監視、病期分類、イメージング及び治療する方法
US6962779B1 (en) 1998-10-02 2005-11-08 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers
US6902892B1 (en) 1998-10-19 2005-06-07 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US20020119158A1 (en) * 1998-12-17 2002-08-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US6468546B1 (en) 1998-12-17 2002-10-22 Corixa Corporation Compositions and methods for therapy and diagnosis of ovarian cancer
US7888477B2 (en) 1998-12-17 2011-02-15 Corixa Corporation Ovarian cancer-associated antibodies and kits
US6670463B1 (en) 1998-12-17 2003-12-30 Corixa Corporation Compositions and methods for therapy of ovarian cancer
US6962980B2 (en) 1999-09-24 2005-11-08 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
AU4484400A (en) * 1999-04-23 2000-11-10 University Of Washington Prostate-specific polynucleotides, polypeptides and their methods of use
JP2003506017A (ja) 1999-07-12 2003-02-18 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング セリパンクリン
AU1807401A (en) 1999-11-30 2001-06-12 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
US20020119156A1 (en) * 2000-03-29 2002-08-29 Sei-Yu Chen Compositions and methods of diagnosing, monitoring, staging, imaging and treating lung cancer
US20020051990A1 (en) * 2000-06-09 2002-05-02 Eric Ople Novel gene targets and ligands that bind thereto for treatment and diagnosis of ovarian carcinomas
AU2001273194A1 (en) * 2000-06-30 2002-01-14 Amgen Inc. B7-Like Molecules and Uses Thereof
DE60138465D1 (de) * 2000-07-12 2009-06-04 Agensys Inc Neues tumor antigen das für diagnose und therapie von blasen-, eierstock-, lungen- und nierenkrebs verwendet werden kann
US20110177082A1 (en) * 2000-07-17 2011-07-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
JP4942906B2 (ja) * 2000-07-17 2012-05-30 コリクサ コーポレイション 卵巣癌の治療および診断のための組成物および方法
WO2002010187A1 (en) 2000-07-27 2002-02-07 Mayo Foundation For Medical Education And Research B7-h3 and b7-h4, novel immunoregulatory molecules
US8010295B1 (en) * 2000-11-06 2011-08-30 IB Security Holders LLC System and method for selectively classifying a population
CA2373468A1 (en) 2001-03-16 2002-09-16 Ortho-Clinical Diagnostics, Inc. Reg-like protein
AU2003249691A1 (en) * 2002-06-07 2003-12-22 Avalon Pharmaceuticals, Inc Cancer-linked gene as target for chemotherapy
EP1617214A4 (en) * 2003-04-23 2008-01-23 Eisai R&D Man Co Ltd METHOD FOR CREATING A DISEASE PROGNOSTIC MODEL, METHOD FOR PREDICTING DISEASE PROGNOSIS USING THE MODEL, DEVICE FOR PREDICTING PROGNOSIS OF DISEASE USING THE MODEL, PROGRAM THEREFOR, AND RECORDING MEDIUM
US7619068B2 (en) 2003-05-09 2009-11-17 Diadexus, Inc. Ovr110 antibody compositions and methods of use
EP1633850A4 (en) * 2003-05-16 2007-04-04 Diadexus Inc OVR115 ANTIBODY COMPOSITIONS AND METHODS OF USE
TWI232608B (en) * 2004-03-26 2005-05-11 Nan Ya Printed Circuit Board Flat panel direct methanol fuel cell and method of making the same
TWI244792B (en) * 2004-08-18 2005-12-01 Nan Ya Printed Circuit Board C Flat panel direct methanol fuel cell and method of making the same
TWI241048B (en) * 2004-09-01 2005-10-01 Nan Ya Printed Circuit Board C Method for manufacturing bipolar plate and direct methanol fuel cell
WO2006053110A2 (en) * 2004-11-10 2006-05-18 Diadexus, Inc. Ovr110 antibody compositions and methods of use
DK1841793T3 (da) * 2005-01-07 2010-07-19 Diadexus Inc Ovr110-antistofsammensætninger og fremgangsmåder til anvendelse deraf
US8759490B2 (en) 2005-03-24 2014-06-24 Millennium Pharamaceuticals, Inc. Antibodies that bind OV064 and methods of use therefor
EP1868647A4 (en) * 2005-03-24 2009-04-01 Millennium Pharm Inc OV064 BINDING ANTIBODIES AND METHOD FOR THEIR USE
US9957569B2 (en) 2005-09-12 2018-05-01 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
CA2622295C (en) 2005-09-12 2019-01-15 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
US8609816B2 (en) 2005-12-08 2013-12-17 Medarex, L.L.C. Human monoclonal antibodies to O8E
DE102005059242A1 (de) 2005-12-12 2007-06-14 Johannes Gutenberg-Universität Mainz, Vertreten Durch Den Präsidenten Molekulare Marker für eine Tumordiagnose und -therapie
US20070190239A1 (en) * 2006-02-14 2007-08-16 Hsi-Ming Shu Method of forming serial or parallel fuel cell units
TWM298782U (en) * 2006-04-18 2006-10-01 Antig Tech Co Ltd Power collecting board used for fuel cell
US20080020257A1 (en) * 2006-07-20 2008-01-24 Hsi-Ming Shu Fuel cell device with electronic identification
US20080050637A1 (en) * 2006-08-22 2008-02-28 Georgia Tech Research Corporation Microfabricated Fuel Cell
AU2007325283B2 (en) 2006-11-27 2012-08-30 Diadexus, Inc. Ovr110 antibody compositions and methods of use
US7989173B2 (en) 2006-12-27 2011-08-02 The Johns Hopkins University Detection and diagnosis of inflammatory disorders
EP2586458B1 (en) 2006-12-27 2016-08-24 The Johns Hopkins University Compositions and methods for treating inflammation and auto-immune diseases
US9303291B2 (en) 2007-07-06 2016-04-05 The Regents Of The University Of Michigan MIPOL1-ETV1 gene rearrangements
US8106037B2 (en) 2007-08-03 2012-01-31 The Brigham And Women's Hospital, Inc. Identification and treatment of estrogen responsive prostate tumors
US9365644B2 (en) * 2008-04-23 2016-06-14 Epitomics, Inc. Anti-TNFα antibody
US8383280B2 (en) * 2008-08-12 2013-02-26 Amir Niroumand Fuel cell separator plate with integrated heat exchanger
EP2473523A2 (en) 2009-08-31 2012-07-11 Amplimmune, Inc. Methods and compositions for the inhibition of transplant rejection
US9938582B2 (en) 2009-09-17 2018-04-10 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
AU2011252851B2 (en) * 2010-05-14 2016-10-06 The Board Of Trustees Of The Leland Stanford Junior University Humanized and chimeric monoclonal antibodies to CD47
US8945556B2 (en) 2010-11-19 2015-02-03 The Regents Of The University Of Michigan RAF gene fusions
US9676854B2 (en) 2011-08-15 2017-06-13 Medimmune, Llc Anti-B7-H4 antibodies and their uses
AU2013361275B2 (en) 2012-12-19 2016-11-24 Amplimmune, Inc. Anti-human B7-H4 antibodies and their uses
US10761081B2 (en) * 2016-06-12 2020-09-01 Mohammad Abdolahad Method and system for metastasis diagnosis and prognosis
CN112566934B (zh) 2018-01-23 2024-09-17 奈斯科尔公司 B7-h4抗体及其使用方法
US20210310008A1 (en) * 2018-08-07 2021-10-07 The Regents Of The University Of Colorado, A Body Corporate Parn as a biomarker and therapeutic target
WO2020138339A1 (ja) * 2018-12-28 2020-07-02 本田技研工業株式会社 製品管理方法

Family Cites Families (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733738A (en) 1983-08-17 1998-03-31 Ligand Pharmaceuticals Polypeptide-induced monoclonal receptors to protein ligands
US5674682A (en) * 1992-10-29 1997-10-07 Thomas Jefferson University Nucleic acid primers for detecting micrometastasis of prostate cancer
US5639656A (en) * 1994-03-31 1997-06-17 Medical College Of Hampton Road Antibodies reactive with biological markers of benign prostate hyperplasia
WO1996039419A1 (en) * 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Colon specific genes and proteins
JPH09149790A (ja) 1995-09-29 1997-06-10 Suntory Ltd 新規セリンプロテアーゼ
US6090620A (en) 1995-12-29 2000-07-18 University Of Washington Genes and gene products related to Werner's syndrome
ATE423852T1 (de) * 1996-04-05 2009-03-15 Antonio Giordano Methoden zur diagnose und prognose von krebs
DE69738157T2 (de) 1996-10-01 2008-05-08 Bio-Rad Laboratories, Inc., Hercules Polymorphismus und neue gene in der region des menschlichen hemochromatosisgens
WO1998021331A1 (en) * 1996-11-12 1998-05-22 Incyte Pharmaceuticals, Inc. Human breast tumor-specific proteins
WO1998056804A1 (en) 1997-06-13 1998-12-17 Human Genome Sciences, Inc. 86 human secreted proteins
US7109318B2 (en) 1997-06-16 2006-09-19 Genentech, Inc. Nucleic acids encoding PRO830
US20020132252A1 (en) 1997-06-16 2002-09-19 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20050196832A1 (en) * 1997-09-18 2005-09-08 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030082767A1 (en) 1997-09-18 2003-05-01 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030064452A1 (en) 1997-10-29 2003-04-03 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO1999025850A1 (en) * 1997-11-17 1999-05-27 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
JP2001523472A (ja) 1997-11-18 2001-11-27 アボット・ラボラトリーズ 乳房の疾患の検出に有用な試薬および方法
US20020034749A1 (en) 1997-11-18 2002-03-21 Billing-Medel Patricia A. Reagents and methods useful for detecting diseases of the breast
US6203979B1 (en) 1998-01-16 2001-03-20 Incyte Pharmaceuticals, Inc. Human protease molecules
WO1999045147A1 (en) * 1998-03-05 1999-09-10 Diadexus Llc A novel method of detecting and monitoring endometrial and uterine cancers
US20030049752A1 (en) 1998-03-20 2003-03-13 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030096351A1 (en) 1998-03-27 2003-05-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030049755A1 (en) 1998-04-08 2003-03-13 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP3538381B2 (ja) * 1998-05-21 2004-06-14 ダイアデクスアス・インコーポレーテッド 結腸癌を診断し、モニターし、そして病期決定する新規方法
CA2328138A1 (en) * 1998-05-21 1999-11-25 Diadexus Llc A novel method of diagnosing, monitoring, and staging lung cancer
IL139686A0 (en) 1998-06-02 2002-02-10 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030105298A1 (en) * 1998-06-16 2003-06-05 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6914130B2 (en) 1998-06-17 2005-07-05 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US20030050465A1 (en) 1998-08-10 2003-03-13 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030166132A1 (en) 1998-08-26 2003-09-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
NZ510464A (en) 1998-09-01 2004-05-28 Genentech Inc Further pro polypeptides and sequences thereof
US20050181478A1 (en) * 1998-09-01 2005-08-18 Baker Kevin P. Secreted and transmembrane polypeptides and nucleic acids encoding the same
ATE413466T1 (de) 1998-09-02 2008-11-15 Diadexus Inc Verfahren zur diagnose, bewertung sowie bilddarstellung verschiedener krebserkrankungen
JP2002531061A (ja) 1998-09-30 2002-09-24 ミレニアム ファーマシューティカルズ インク． 前立腺癌の診断および治療において有用な特異的核酸およびポリペプチドの発現解析
US20020119158A1 (en) 1998-12-17 2002-08-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US20030091580A1 (en) 2001-06-18 2003-05-15 Mitcham Jennifer L. Compositions and methods for the therapy and diagnosis of ovarian cancer
US6670463B1 (en) 1998-12-17 2003-12-30 Corixa Corporation Compositions and methods for therapy of ovarian cancer
US6468546B1 (en) 1998-12-17 2002-10-22 Corixa Corporation Compositions and methods for therapy and diagnosis of ovarian cancer
US6528253B1 (en) 1998-12-17 2003-03-04 Corixa Corporation Compositions and methods for diagnosis of ovarian cancer
US6699664B1 (en) 1998-12-17 2004-03-02 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US6962980B2 (en) 1999-09-24 2005-11-08 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US6488931B1 (en) 1998-12-17 2002-12-03 Corixa Corporation Compositions and methods for therapy and diagnosis of ovarian cancer
US20030009013A1 (en) 1998-12-30 2003-01-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20050175994A1 (en) * 1999-01-20 2005-08-11 Haley-Vicente Dana A. Methods and materials relating to prothrombinase-like polypeptides and polynucleotides
US20050208488A1 (en) * 1999-01-20 2005-09-22 Boyle Bryan J Methods and materials relating to novel von willerband/thrombospondin-like polypeptides and polynucleotides
CA2296792A1 (en) 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
US6773878B1 (en) * 1999-11-09 2004-08-10 Eos Biotechnology, Inc. Methods of diagnosing of colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
US6294343B1 (en) * 1999-11-09 2001-09-25 Eos Biotechnology, Inc. Methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
EP1159619A2 (en) 1999-03-15 2001-12-05 EOS Biotechnology, Inc. Methods of diagnosing and treating breast cancer
EP1163524A2 (en) 1999-03-15 2001-12-19 EOS Biotechnology, Inc. Methods of screening for colorectal cancer modulators
US6316272B1 (en) * 1999-03-15 2001-11-13 Eos Biotechnology, Inc. Methods of diagnosis of colorectal cancer and methods of screening for colorectal cancer modulators
JP2004522402A (ja) 1999-06-02 2004-07-29 ジェネンテック・インコーポレーテッド 同一のものをコードする分泌及び膜貫通ポリペプチドと核酸
AU5177100A (en) 1999-06-11 2001-01-02 Human Genome Sciences, Inc. 47 human secreted proteins
AU2883700A (en) 1999-06-23 2001-01-09 Genentech Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU5638400A (en) 1999-06-23 2001-01-09 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
CA2384713A1 (en) * 1999-09-29 2001-04-05 Human Genome Sciences, Inc. Colon and colon cancer associated polynucleotides and polypeptides
AU1807401A (en) 1999-11-30 2001-06-12 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
US6465620B1 (en) * 2000-01-21 2002-10-15 Hyseq, Inc. Methods and materials relating to novel von Willebrand/Thrombospondin-like polypeptides and polynucleotides
US6635742B1 (en) * 2000-01-25 2003-10-21 Nuvelo, Inc. Antibodies specific for semaphorin-like polypeptides
US6569662B1 (en) * 2000-01-21 2003-05-27 Hyseq, Inc. Nucleic acids and polypeptides
US6586390B1 (en) * 2000-01-21 2003-07-01 Hyseq, Inc. Methods and materials relating to novel prothrombinase-like polypeptides and polynucleotides
EP1248848B1 (en) * 1999-12-23 2007-02-28 Kirin Beer Kabushiki Kaisha Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides
AU2001227385A1 (en) * 2000-01-21 2001-07-31 Hyseq, Inc. Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides
US20030219744A1 (en) * 2000-01-21 2003-11-27 Tang Y. Tom Novel nucleic acids and polypeptides
US20020146692A1 (en) * 2000-01-21 2002-10-10 Victoria Yamazaki Methods and materials relating to G protein-coupled receptor-like polypeptides and polynucleotides
US20050192215A1 (en) * 2000-01-21 2005-09-01 Malabika Ghosh Methods and materials relating to novel polypeptides and polynucleotides
US20050170374A1 (en) * 2000-01-21 2005-08-04 Nuvelo, Inc. Novel nucleic acids and polypeptides
US20030224379A1 (en) * 2000-01-21 2003-12-04 Tang Y. Tom Novel nucleic acids and polypeptides
US20040219521A1 (en) * 2000-01-21 2004-11-04 Tang Y. Tom Novel nucleic acids and polypeptides
US20040048249A1 (en) * 2000-01-21 2004-03-11 Tang Y. Tom Novel nucleic acids and secreted polypeptides
US6455668B1 (en) * 2000-01-28 2002-09-24 Eos Biotechnology, Inc. Methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
US6566502B1 (en) * 2000-01-28 2003-05-20 Eos Biotechnology, Inc. Methods of diagnosing cancer, compositions, and methods of screening for cancer modulators
US20020051990A1 (en) 2000-06-09 2002-05-02 Eric Ople Novel gene targets and ligands that bind thereto for treatment and diagnosis of ovarian carcinomas
US20030170818A1 (en) * 2000-06-17 2003-09-11 Haley Dana A. Methods and materials relating to novel prothrombinase-like polypeptides and polynucleotides
AU2001273194A1 (en) 2000-06-30 2002-01-14 Amgen Inc. B7-Like Molecules and Uses Thereof
EP1301524A1 (en) 2000-06-30 2003-04-16 Human Genome Sciences, Inc. B7-like polynucleotides, polypeptides, and antibodies
US20040053248A1 (en) * 2000-12-22 2004-03-18 Tang Y. Tom Novel nucleic acids and polypeptides
US20030021572A1 (en) * 2001-02-07 2003-01-30 Steinberg Dan A. V-groove with tapered depth and method for making
EP1241725B1 (en) * 2001-03-16 2010-05-12 Samsung SDI Co., Ltd. Monopolar cell pack of direct methanol fuel cells
MXPA03011979A (es) 2001-06-18 2005-04-08 Eos Biotechnology Inc Metodos de diagnostico de cancer de ovario composiciones y metodos para rastrear moduladores de cancer de ovario.
US20030023042A1 (en) 2001-12-06 2003-01-30 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7619068B2 (en) * 2003-05-09 2009-11-17 Diadexus, Inc. Ovr110 antibody compositions and methods of use
US20060194098A1 (en) * 2005-02-28 2006-08-31 Antig Technology Co,Ltd. Manufacturing method of flexible substrate laminate integrated fuel cell and fuel cell thereof

Also Published As

Publication number Publication date
EP2053129A2 (en) 2009-04-29
JP2002523760A (ja) 2002-07-30
JP2007126463A (ja) 2007-05-24
ATE413466T1 (de) 2008-11-15
EP1109937A4 (en) 2002-09-25
PT1109937E (pt) 2009-02-10
WO2000012758A1 (en) 2000-03-09
ES2317704T3 (es) 2009-04-16
EP2053129A3 (en) 2009-08-19
JP2004137279A (ja) 2004-05-13
CA2341142A1 (en) 2000-03-09
EP1109937A1 (en) 2001-06-27
DE69939874D1 (de) 2008-12-18
US20100284910A1 (en) 2010-11-11
US8029787B2 (en) 2011-10-04
US20120014872A1 (en) 2012-01-19
JP2005120099A (ja) 2005-05-12
US20050158241A1 (en) 2005-07-21
EP2053129A8 (en) 2009-06-17
US20050158608A1 (en) 2005-07-21
EP1109937B1 (en) 2008-11-05
US7737255B1 (en) 2010-06-15
US20050158242A1 (en) 2005-07-21

Similar Documents

Publication Publication Date Title
EP2053129A8 (en) Method of diagnosing, monitoring, staging, imaging and treating various cancers
AU6275799A (en) Ykl-40 as a marker and prognostic indicator for cancers
WO2004060302A3 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
EP1080227A4 (en) NEW METHOD FOR DIAGNOSING, MONITORING AND STADIFYING COLON CANCER
WO2001073030A3 (en) Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer
EP1474528A4 (en) METHODS OF DIAGNOSIS OF PROSTATE CANCER, COMPOSITIONS AND METHODS OF EXAMINING PROSTATE CANCER MODULATORS
NO20013002D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av ovariekreft
EP1161680A4 (en) METHOD FOR DIAGNOSTICING AND MONITORING Malignant Breast Carcinomas
WO2001037779A3 (en) A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
ATE410446T1 (de) Zusammensetzungen zur behandlung und diagnose von eierstockkrebs
WO2004021008A3 (en) Methods for detecting breast and ovarian cancer
AU2003253440A8 (en) Method of diagnosing ovarian endometriosis
NO20005696L (no) BASB029-polynukleotid(er) og polypeptider fra Neisseria Meningitidis
SG165370A1 (en) Method for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e-related metabolites
WO2004021009A3 (en) Methods for detecting endocrine cancer using kallikrein 13 (klk13) as a biomarker
NO20014805D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av brystkreft
EP1107006A4 (en) METHOD FOR DIAGNOSING BONE METASTASES AND MALIGNING TUMORS
DE60036935D1 (de) Diagnostisches Verfahren für Eierstock- und Endometriumtumore basierend auf dem Nachweis des L1-Adhäsionsmoleküls
AU2001241656A1 (en) Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
EP1115426A4 (en) METHOD FOR DIAGNOSIS, DETERMINATION, CLASSIFICATION, DISPLAY AND TREATMENT OF GYNECOLOGICAL CANCER DISEASES AND TESTICULAR CANCER
AU2001294165A1 (en) Apparatus for prostate cancer diagnose
WO2002006515A3 (en) Method of diagnosing, monitoring, staging, imaging and treating colon cancer
CY1109406T1 (el) Καινοτομος μεθοδος διαγνωσης, παρακολουθησης, διαβαθμισης, απεικονισης και αντιμετωπισης διαφορων καρκινων
DK1078064T3 (da) Forbindelser fra moraxella catarrhalis
ATA19972000A (de) Pibf für die diagnose von tumoren